Lv3
330 积分 2022-05-11 加入
A new paliperidone palmitate formulation: how is it different and where does it fit in our array of choices for long-acting formulations of risperidone and paliperidone?
6天前
已完结
Temporal trends of antipsychotic utilization patterns in 62,607 patients with schizophrenia-spectrum disorders in Hong Kong: An 11-year population-based study with joinpoint regression analysis
1个月前
已完结
Long-Acting Injectable Antipsychotics in Adolescents with Bipolar Disorder
1个月前
已完结
Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable
2个月前
已完结
Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Multicenter Study
3个月前
已完结
精神分裂症患者代谢综合征管理的中国专家共识
4个月前
已完结
躯体症状障碍多学科诊疗专家共识
5个月前
已完结
Pharmacokinetics and Safety of a Novel Extended-Release Microsphere Formulation of Risperidone in Patients with Schizophrenia or Schizoaffective Disorder
5个月前
已关闭
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
5个月前
已完结
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
5个月前
已完结
皖公网安备34019202002308
